Assessing B-cell depletion and disease activity in a french multiple sclerosis cohort treated by long-term anti-CD20 antibody therapy

被引：0
|
作者：
Freeman, S. [1 ]
Lemarchant, B. [1 ,2 ]
Alberto, T. [1 ]
Drelon, A. [1 ]
Boucher, J. [1 ]
Dubucquoi, S. [3 ]
Zephir, H. [1 ,2 ]
机构：
[1] Univ Lille, Dept Neurol, CRC SEP, CHU Lille, Lille, France
[2] Univ Lille, INSERM, CHU Lille, Lille, France
[3] Univ Lille, INSERM, CHU Lille, U1286,INFINITE Institute Translat Res Inflammat, Lille, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P328
引用
收藏
页码：355 / 356
页数：2
相关论文
共 50 条
  • [21] Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
    Klaus Lehmann-Horn
    Eva Schleich
    Deetje Hertzenberg
    Alexander Hapfelmeier
    Tania Kümpfel
    Nikolas von Bubnoff
    Reinhard Hohlfeld
    Achim Berthele
    Bernhard Hemmer
    Martin S Weber
    Journal of Neuroinflammation, 8
  • [22] T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma
    Vincent-Salomon, A
    Mathiot, C
    MacIntyre, E
    Girre, V
    Fourquet, A
    Mercier, C
    Fréneaux, P
    Dumont, J
    Decaudin, D
    LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 387 - +
  • [23] Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
    Lehmann-Horn, K.
    Schleich, E.
    Hertzenberg, D.
    Hapfelmeier, A.
    Kuempfel, T.
    von Bubnhoff, N.
    Hohlfeld, R.
    Berthele, A.
    Hemmer, B.
    Weber, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S519 - S519
  • [24] CD20-negative relapse of cutaneous B-cell lymphoma after anti-CD20 monoclonal antibody therapy
    Massengale, WT
    McBurney, E
    Gurtler, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (03) : 441 - 443
  • [25] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
  • [26] Characterization of a humanized anti-CD20 antibody with potent antitumor activity against B-cell lymphoma
    Wu, Lan
    Wang, Chong
    Zhang, Dapeng
    Zhang, Xunming
    Qian, Weizhu
    Zhao, Lei
    Wang, Hao
    Li, Bohua
    Guo, Yajun
    CANCER LETTERS, 2010, 292 (02) : 208 - 214
  • [27] Anti-CD20 B-Cell Depletion Increases the Frequency of Regulatory T Cells, but Enhances Monocyte Reactivity in Multiple Sclerosis and Neuromyelitis Optica
    Lehmann-Horn, Klaus
    Schleich, Eva
    Hertzenberg, Deerje
    Kuempfel, Tania
    Hohlfeld, Reinhard
    Berthele, Achim
    Hemmer, Bernhard
    Weber, Martin S.
    NEUROLOGY, 2011, 76 (09) : A533 - A533
  • [28] Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
    Rouzière, A
    Kneitz, C
    Palanichamy, A
    Dörner, T
    Tony, HP
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (04) : R714 - R724
  • [29] Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
    Anne-Sophie Rouzière
    Christian Kneitz
    Arumugam Palanichamy
    Thomas Dörner
    Hans-Peter Tony
    Arthritis Research & Therapy, 7
  • [30] The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura
    Cooper, N
    Stasi, R
    Cunningham-Rundles, SS
    Feuerstein, MA
    Leonard, JP
    Amadori, S
    Bussel, JB
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (02) : 232 - 239
12345